Suppr超能文献

口腔鳞状细胞癌中免疫组织化学标志物的评估

Evaluation of immuno-histochemical markers in oral squamous cell carcinoma.

作者信息

Guruprasad Yadavalli, Singhal Priya, Gupta Neha, Kukreja Bhavna Jha, Gupta Bharti, Kukreja Pankaj, Makkad Ramanpal Singh, Mehta Dhaval Niranjan

机构信息

Department of Dentistry, Vijaynagar Institute of Medical Sciences, VIMS Campus, Cantonment, Ballari - 583104, India.

Senior Resident, Department of Dentistry, SMS Medical College, Jaipur, India.

出版信息

Bioinformation. 2023 Dec 31;19(13):1399-1404. doi: 10.6026/973206300191399. eCollection 2023.

Abstract

Evaluation of immuno-histochemical (IHC) markers like p53, p63, PDPN, C-erb-B2, CK19, and VEGF in oral squamous cell carcinoma (OSCCs) is of interest to dentists. Sixty formalin-fixed paraffin embedded tissue blocks from the Department of Oral Pathology, New Horizon Dental College and Research, Institute, Sakri, Bilaspur, Chhattisgarh, India. The conventional IHC method was used to assess the expression of p53, p63, PDPN, C- erb-B2, CK19 and VEGF using the different antibodies. Data shows that P53, p63 had high values of labeling index (LI) of staining while PDPN, C-erb-B2 had low values of LI of staining. The values of LI of staining for CK19, and VEGF were in between the two types of IHCs. Combining the analysis of multiple IHC markers for OSCC can yield precise cancer diagnosis results.

摘要

对口腔鳞状细胞癌(OSCC)中p53、p63、PDPN、C-erb-B2、CK19和VEGF等免疫组织化学(IHC)标志物的评估受到牙医的关注。来自印度恰蒂斯加尔邦比拉斯布尔市萨克里新地平线牙科学院和研究所口腔病理科的60个福尔马林固定石蜡包埋组织块。采用传统免疫组织化学方法,使用不同抗体评估p53、p63、PDPN、C-erb-B2、CK19和VEGF的表达。数据显示,P53、p63的染色标记指数(LI)值较高,而PDPN、C-erb-B2的染色LI值较低。CK19和VEGF的染色LI值介于两种免疫组织化学类型之间。联合分析多种OSCC免疫组织化学标志物可得出精确的癌症诊断结果。

相似文献

1
Evaluation of immuno-histochemical markers in oral squamous cell carcinoma.
Bioinformation. 2023 Dec 31;19(13):1399-1404. doi: 10.6026/973206300191399. eCollection 2023.
3
Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038. Epub 2013 Jun 18.
4
A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Cureus. 2023 May 2;15(5):e38467. doi: 10.7759/cureus.38467. eCollection 2023 May.
6
Expression analysis of cyclin D, Ki-67, MCM3 and MCM2 in oral squamous cell carcinoma.
Bioinformation. 2023 Dec 31;19(13):1405-1410. doi: 10.6026/973206300191405. eCollection 2023.
8
Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
J Oral Pathol Med. 2007 Apr;36(4):191-7. doi: 10.1111/j.1600-0714.2007.00517.x.
10
Expression of p53 and Cyclin D1 in oral squamous cell carcinoma and normal mucosa: An Immunohistochemical study.
J Oral Maxillofac Pathol. 2012 May;16(2):172-7. doi: 10.4103/0973-029X.98451.

引用本文的文献

1
Correlation of Histological Grading with Regional Metastasis in Oral Squamous Cell Carcinoma - A Cross-Sectional Study.
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S764-S766. doi: 10.4103/jpbs.jpbs_170_25. Epub 2025 Apr 9.

本文引用的文献

1
A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Cureus. 2023 May 2;15(5):e38467. doi: 10.7759/cureus.38467. eCollection 2023 May.
2
Diagnostic Utility of Cytokeratin 17 Expression in Oral Squamous Cell Carcinoma: A Review.
Cureus. 2022 Jul 19;14(7):e27041. doi: 10.7759/cureus.27041. eCollection 2022 Jul.
3
Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma.
J Oral Maxillofac Pathol. 2022 Jan-Mar;26(1):127-128. doi: 10.4103/jomfp.jomfp_310_21. Epub 2022 Mar 31.
4
Prevalence of Trismus and Its Impact on Oral Health-Related Quality of Life in Patients Treated for Oral Squamous Cell Carcinoma.
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2437-2444. doi: 10.31557/APJCP.2021.22.8.2437.
6
Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC) by miR-138 and miR-424-5p Expression as a Cancer Marker.
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):2185-2189. doi: 10.31557/APJCP.2021.22.7.2185.
7
leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma.
Cancer Manag Res. 2019 Jul 4;11:6201-6214. doi: 10.2147/CMAR.S197557. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验